Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM
Open Access
- 1 August 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 124 (8) , 1591-1596
- https://doi.org/10.1038/sj.bjp.0701989
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antazoline increases insulin secretion and improves glucose tolerance in rats and dogsEuropean Journal of Pharmacology, 1997
- The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1‐ and I2‐sitesBritish Journal of Pharmacology, 1994
- Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080British Journal of Pharmacology, 1993
- Biguanides and NIDDMDiabetes Care, 1992
- Evidence for a direct stimulatory effect of cibenzoline on insulin secretion in ratsEuropean Journal of Pharmacology, 1992
- Insulin Resistance in Skeletal Muscles in Patients With NIDDMDiabetes Care, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cellsEuropean Journal of Pharmacology, 1991
- Stimulation of insulin secretion by efaroxan may involve interaction with potassium channelsEuropean Journal of Pharmacology, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976